{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:57:50Z","timestamp":1793465870600,"version":"4.5.0"},"reference-count":30,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,7,25]]},"DOI":"10.1253\/circj.cj-19-0255","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T18:03:00Z","timestamp":1560362580000},"page":"1698-1708","source":"Crossref","is-referenced-by-count":51,"title":["Combination of Commonly Examined Parameters Is a Useful Predictor of Positive &lt;sup&gt;99 m&lt;\/sup&gt;Tc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis"],"prefix":"10.1253","volume":"83","author":[{"given":"Kyohei","family":"Marume","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Izumiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Falk RH. Diagnosis and management of the cardiac amyloidoses. <i>Circulation<\/i> 2005; 112: 2047\u20132060.","DOI":"10.1161\/CIRCULATIONAHA.104.489187"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Falk RH, Dubrey SW. Amyloid heart disease. <i>Prog Cardiovasc<\/i> 2010; 52: 347\u2013361.","DOI":"10.1016\/j.pcad.2009.11.007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. <i>Eur Heart J<\/i> 2015; 36: 2585\u20132594.","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study. <i>Ann Med<\/i> 2008; 40: 232\u2013239.","DOI":"10.1080\/07853890701842988"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. <i>Circulation<\/i> 2007; 116: 2216\u20132233.","DOI":"10.1161\/CIRCULATIONAHA.107.186093"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99 m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. <i>Circ Cardiovasc Imaging<\/i> 2013; 6: 195\u2013201.","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. <i>Circulation<\/i> 2016; 133: 2404\u20132412.","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, et al. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis. <i>ESC Heart Fail<\/i> 2018; 5: 27\u201335.","DOI":"10.1002\/ehf2.12203"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99 mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. <i>J Am Coll Cardiol<\/i> 2005; 46: 1076\u20131084.","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. <i>Clin Chem<\/i> 2010; 56: 254\u2013261.","DOI":"10.1373\/clinchem.2009.132654"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. <i>Clin Exp Nephrol<\/i> 2007; 11: 41\u201350.","DOI":"10.1007\/s10157-006-0453-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tabrizi F, Englund A, Rosenqvist M, Wallentin L, Stenestrand U. Influence of left bundle branch block on long-term mortality in a population with heart failure. <i>Eur Heart J<\/i> 2007; 28: 2449\u20132455.","DOI":"10.1093\/eurheartj\/ehm262"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Willems JL, Robles de Medina EO, Bernard R, Coumel P, Fisch C, Krikler D, et al. Criteria for intraventricular conduction disturbances and pre-excitation: World Health Organizational\/International Society and Federation for Cardiology Task Force Ad Hoc. <i>J Am Coll Cardiol<\/i> 1985; 5: 1261\u20131275.","DOI":"10.1016\/S0735-1097(85)80335-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, et al. Usefulness of combining electrocardiographic and echocardiographic findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation. <i>Am J Cardiol<\/i> 2015; 116: 1122\u20131127.","DOI":"10.1016\/j.amjcard.2015.07.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. <i>J Am Soc Echocardiogr<\/i> 2005; 18: 1440\u20131463.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. <i>J Am Soc Echocardiogr<\/i> 2009; 22: 107\u2013133.","DOI":"10.1016\/j.echo.2008.11.023"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wicker P, Roudaut R, Haissaguere M, Villega-Arino P, Clementy J, Dallocchio M. Prevalence and significance of asymmetric septal hypertrophy in hypertension: An echocardiographic and clinical study. <i>Eur Heart J<\/i> 1983; 4(Suppl G): 1\u20135.","DOI":"10.1093\/eurheartj\/4.suppl_G.1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kansal S, Roitman D, Sheffield LT. Interventricular septal thickness and left ventricular hypertrophy: An echocardiographic study. <i>Circulation<\/i> 1979; 60: 1058\u20131065.","DOI":"10.1161\/01.CIR.60.5.1058"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. <i>J Am Coll Cardiol<\/i> 1992; 19: 1550\u20131558.","DOI":"10.1016\/0735-1097(92)90617-V"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cerisano G, Bolognese L, Buonamici P, Valenti R, Carrabba N, Dovellini EV, et al. Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction. <i>J Am Coll Cardiol<\/i> 2001; 37: 793\u2013799.","DOI":"10.1016\/S0735-1097(00)01203-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gonzalez-Lopez E, Gagliardi C, Dominguez F, Quarta CC, de Haro-Del Moral FJ, Milandri A, et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths. <i>Eur Heart J<\/i> 2017; 38: 1895\u20131904.","DOI":"10.1093\/eurheartj\/ehx043"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pinney JH, Whelan CJ, Petrie A, Dungu J, Banypersad SM, Sattianayagam P, et al. Senile systemic amyloidosis: Clinical features at presentation and outcome. <i>J Am Heart Assoc<\/i> 2013; 2: e000098.","DOI":"10.1161\/JAHA.113.000098"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sekijima Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. <i>Amyloid<\/i> 2018; 25: 8\u201310.","DOI":"10.1080\/13506129.2017.1409706"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. <i>N Engl J Med<\/i> 2018; 379: 1007\u20131016.","DOI":"10.1056\/NEJMoa1805689"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hirakawa K, Takashio S, Marume K, Yamamoto M, Hanatani S, Yamamoto E, et al. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis. <i>ESC Heart Fail<\/i> 2019; 6: 122\u2013130.","DOI":"10.1002\/ehf2.12361"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Castano A, Drachman BM, Judge D, Maurer MS. Natural history and therapy of TTR-cardiac amyloidosis: Emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. <i>Heart Fail Rev<\/i> 2015; 20: 163\u2013178.","DOI":"10.1007\/s10741-014-9462-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. <i>Eur Heart J Cardiovasc Imaging<\/i> 2014; 15: 1289\u20131298.","DOI":"10.1093\/ehjci\/jeu107"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: A prospective, observational cohort study. <i>Circulation<\/i> 2016; 133: 282\u2013290.","DOI":"10.1161\/CIRCULATIONAHA.115.018852"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. <i>Heart<\/i> 2012; 98: 1442\u20131448.","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Cappelli F, Baldasseroni S, Bergesio F, Perlini S, Salinaro F, Padeletti L, et al. Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis. <i>Clin Cardiol<\/i> 2015; 38: 69\u201375.","DOI":"10.1002\/clc.22353"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/8\/83_CJ-19-0255\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T23:17:31Z","timestamp":1564183051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/8\/83_CJ-19-0255\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0255","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]}}}